---
figid: PMC3835685__nihms524354f1
figtitle: Human epidermal growth fa ctor receptor 2 (HER2) signal transduction pathways
organisms:
- NA
pmcid: PMC3835685
filename: nihms524354f1.jpg
figlink: /pmc/articles/PMC3835685/figure/F1/
number: F1
caption: 'Human epidermal growth fa ctor receptor 2 (HER2) signal transduction pathways.
  Homodimerization and heterodimerization of HER2 leads to TK activation and downstream
  signaling via the PI3K/Akt/mammalian target of rapamycin pathway and the Ras/Raf/mitogen-activated
  protein kinase pathway to stimulate processes involved in cell survival and proliferation.Adapted
  from Valabrega G, Montemurro F, Aglietta M. Trastuzumab: mechanism of action, resistance
  and future perspectives in HER2-overexpressing breast cancer. Ann Oncol. 2007;18:977–984,
  by permission of Oxford University Press.'
papertitle: Current approaches and future directions in the treatment of HER2-positive
  breast cancer.
reftext: Sara Hurvitz, et al. Cancer Treat Rev. ;39(3):10.1016/j.ctrv.2012.04.008.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9113973
figid_alias: PMC3835685__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3835685__F1
ndex: 10600ea3-df11-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3835685__nihms524354f1.html
  '@type': Dataset
  description: 'Human epidermal growth fa ctor receptor 2 (HER2) signal transduction
    pathways. Homodimerization and heterodimerization of HER2 leads to TK activation
    and downstream signaling via the PI3K/Akt/mammalian target of rapamycin pathway
    and the Ras/Raf/mitogen-activated protein kinase pathway to stimulate processes
    involved in cell survival and proliferation.Adapted from Valabrega G, Montemurro
    F, Aglietta M. Trastuzumab: mechanism of action, resistance and future perspectives
    in HER2-overexpressing breast cancer. Ann Oncol. 2007;18:977–984, by permission
    of Oxford University Press.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - TGFA
  - AR
  - BTC
  - HBEGF
  - NRG1
  - NRG3
  - NRG2
  - NRG4
  - ERBB2
  - EGFR
  - ERBB3
  - ERBB4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - KRAS
  - HRAS
  - NRAS
  - MTG1
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - PTEN
  - AKT2
  - AKT3
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MTOR
  - MAP2K4
  - RPS6KB1
  - EIF4EBP1
  - UNK
  - Cancer
  - Lung cancer
---
